Genocea Biosciences, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 14.546 million compared to USD 11.161 million a year ago. Net loss was USD 4.311 million compared to USD 11.321 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.39 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.39 a year ago. For the half year, operating loss was USD 26.968 million compared to USD 24.536 million a year ago. Net loss was USD 16.294 million compared to USD 24.174 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.84 a year ago. Diluted loss per share from continuing operations was USD 0.37 compared to USD 0.84 a year ago.